The FirstTake Podcast – AdCom upset for Lilly and Innovent

FirstTake on Pharma - Pharma News and Analysis Podcast

English - February 10, 2022 19:00 - 13 minutes - 11 MB - ★★★★★ - 2 ratings
Science pharma pharmaceutical intelligence firstword firsttake cardiovascular dermatology diabetes immunology infectious diseases Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: The FirstTake Podcast – More Aduhelm fallout and JP Morgan wraps for another year

Next Episode: The FirstTake Podcast – More questions than answers for Sage and Biogen

FirstWord Pharma PLUS editors Michael Flanagan, Virginia Li and Simon King discuss Eli Lilly’s attempt to bring price disruption to the US cancer immunotherapy market, Pfizer and Amgen’s future growth strategies and some new diabetes drugs to keep an eye on.